bioRxiv : the preprint server for biology · 2025
Structure of endogenous Pfs230:Pfs48/45 in complex with potent malaria transmission-blocking antibodies.
СтатьяПрепринтНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bekkering Ezra T, Yoo Randy, Hailemariam Sophia, Heide Fabian, Ivanochko Danton, Jackman Matthew, Proellochs Nicholas I, Stoter Rianne, van Gemert Geert-Jan, Maeda Ayana, Yuguchi Takaaki, Wanders Oscar T, van Daalen Renate C, Inklaar Maartje R, Andrade Carolina M, Jansen Pascal W T C, Vermeulen Michiel, Bousema Teun, Takashima Eizo, Rubinstein John L, Kooij Taco W A, Jore Matthijs M, Julien Jean-Philippe
Аннотация
The Pfs230:Pfs48/45 complex forms the basis for leading malaria transmission-blocking vaccine candidates, yet little is known about its molecular assembly. Here, we used cryogenic electron microscopy to elucidate the structure of the endogenous Pfs230:Pfs48/45 complex bound to six potent transmission-blocking antibodies. Pfs230 consists of multiple domain clusters rigidified by interactions mediated through insertion domains. Membrane-anchored Pfs48/45 forms a disc-like structure and interacts with a short C-terminal peptide on Pfs230 that is critical for Pfs230 membrane-retention in vivo. Interestingly, membrane retention through this interaction is not essential for transmission to mosquitoes, suggesting that complex disruption is not a mode of action for transmission-blocking antibodies. Analyses of Pfs48/45- and Pfs230-targeted antibodies identify conserved epitopes on the Pfs230:Pfs48/45 complex and provides a structural paradigm for complement-dependent activity of Pfs230-targeting antibodies. Altogether, the antibody-bound Pfs230:Pfs48/45 structure presented improves our molecular understanding of this biological complex, informing the development of next-generation Plasmodium falciparum transmission-blocking interventions.